314
Views
0
CrossRef citations to date
0
Altmetric
Perspective

The role of autophagy in acute myeloid leukemia development

, , & ORCID Icon
Pages 5-18 | Received 05 May 2022, Accepted 19 Dec 2022, Published online: 02 Jan 2023

References

  • Li L, Liu W, Sun Q. Decitabine downregulates tigar to induce apoptosis and autophagy in myeloid leukemia cells. Oxid Med Cell Longev. 2021;8877460:1–15.
  • Short NJ, Konopleva M, Kadia TM, et al. Advances in the treatment of acute myeloid leukemia: new drugs and new challenges. Cancer Discov. 2020;10(4):506–525.
  • Benard B, Gentles AJ, Kohnke T, et al. Data mining for mutation-specific targets in acute myeloid leukemia. Leukemia. 2019;33(4):826–843.
  • Antar AI, Otrock ZK, Jabbour E, et al. FLT3 inhibitors in acute myeloid leukemia: ten frequently asked questions. Leukemia. 2020;34(3):682–696.
  • Liu X, Gong Y. Isocitrate dehydrogenase inhibitors in acute myeloid leukemia. Biomark Res. 2019;7(22). DOI:10.1186/s40364-019-0173-z
  • Konopleva M, Letai A. BCL-2 inhibition in AML: an unexpected bonus? Blood. 2018;132(10):1007–1012.
  • Watson AS, Riffelmacher T, Stranks A, et al. Autophagy limits proliferation and glycolytic metabolism in acute myeloid leukemia. Cell Death Dis. 2015;1(1):15008.
  • Liu Q, Chen L, Atkinson JM, et al. Atg5-dependent autophagy contributes to the development of acute myeloid leukemia in an MLL-AF9-driven mouse model. Cell Death Dis. 2016;7(9):e2361.
  • Tao YF, Li ZH, Du WW, et al. Inhibiting PLK1 induces autophagy of acute myeloid leukemia cells via mammalian target of rapamycin pathway dephosphorylation. Oncol Rep. 2017;37(3):1419–1429.
  • Yamamoto JF, Goodman MT. Patterns of leukemia incidence in the United States by subtype and demographic characteristics. Cancer Causes Control. 2018;19(4):379–390.
  • Djavaheri-Mergny M, Giuriato S, Tschan M, et al. Therapeutic modulation of autophagy in leukaemia and lymphoma. Cells. 2018;8(2):103.
  • Joffre C, Decau C, Poillet-Perez L, et al. Autophagy a close relative of AML biology. Biology (Basel). 2021;10(6):552.
  • Du W, Xu A, Huang Y, et al. The role of autophagy in targeted therapy for acute myeloid leukemia. Autophagy. 2021;17(10): 2665–2679. .
  • Axe EL, Walker SA, Manifava M. Autophagosome formation from membrane compartments enriched in phosphatidylinositol 3-phosphate and dynamically connected to the endoplasmic reticulum. J Cell Biol. 2008;182(4):685–701.
  • Jung CH, Jun CB, Ro SHAA. ULK-Atg13-FIP200 complexes mediate mTOR signaling to the autophagy machinery. Mol Biol Cell. 2009;20(7):1992–2003.
  • Young ARJ, Narita M, Ferreira MAA. Autophagy mediates the mitotic senescence transition. Gen Dev. 2009;23(7):798–803.
  • Suzuki K, Kirisako T, Kamada YAA. The pre-autophagosomal structure organized by concerted functions of APG genes is essential for autophagosome formation. EMBO J. 2001;20(21):5971–5981.
  • Tsuboyama K, Koyama-Honda I, Sakamaki Y, et al. The ATG conjugation systems are important for degradation of the inner autophagosomal membrane. Science. 2016;354(6315):1036–1041.
  • Azad MB, Chen Y, Henson ES, et al. Hypoxia induces autophagic cell death in apoptosis-competent cells through a mechanism involving BNIP3. Autophagy. 2008;4(2):195–204.
  • Kuma A, Hatano M, Matsi M, et al. The role of autophagy during the early neonatal starvation period. Nature. 2004;432(7020):1032–1036.
  • Mizushima N, Komatsu M. Autophagy: renovation of cells and tissues. Cell. 2011;147(4):728–741.
  • Hara T, Nakamara K, Matsui M, et al. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature. 2006;441(7095):885–889.
  • Kabeya Y, Mizushima N, Ueno T, et al. LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J. 2000;19(21):5720–5728.
  • Hosokawa Hara TKT, Hara T, Kaizuka T, et al. Nutrient-dependent mTORC1 association with the ULK1-Atg13-FIP200 complex required for autophagy. Mol Biol Cell. 2009;20(7):1981–1991.
  • Pattingree S, Tassa A, Qu X, et al. Bcl-2 antiapoptotic proteins inhibit beclin 1-dependent autophagy. Cell. 2005;122(6):927–939.
  • Ravikumar B, Vacher C, Berger Z, et al. Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat Genet. 2004;36(6):585–595.
  • Maiuri MC, Le Toumelin G, Criollo C, et al. Functional and physical interaction between Bcl-X(L) and a BH3-like domain in Beclin-1. EMBO J. 2007;26(10):2527–2539.
  • Kamada Y, Funakoshi T, Shintani T, et al. Tor-mediated induction of autophagy via an Apg1 protein kinase complex. J Cell Biol. 2000;150(6):1507–1513.
  • Groulx JF, Khalfaoui T, Benoit YD. Autophagy is active in normal colon mucosa. Autophagy. 2012;8(6):893–902.
  • Mizushima N, Yamamoto A, Hatano M, et al. Dissection of autophagosome formation using Apg5-deficient mouse embryonic stem cells. J Cell Biol. 2001;152(4):657–667.
  • Jäger S, Bucci C, Tanida I, et al. Role for Rab7 in maturation of late autophagic vacuoles. J Cell Sci. 2004;117(20):4837–4848.
  • Levine B. Cell biology: autophagy and cancer. Nature. 2007;446(7137):745–747.
  • Paglin S, Hollister T, Delohery T, et al. A novel response of cancer cells to radiation involves autophagy and formation of acidic vesicles. Cancer Res. 2001;61(2):439–444.
  • Bursch W, Hochegger K, Torok L, et al. Autophagic and apoptotic types of programmed cell death exhibit different fates of cytoskeletal filaments. J Cell Sci. 2001;113(7):1189–1198.
  • Chen X, Sun Y, Wang B. Prognostic significance of autophagy-related genes Beclin1 and LC3 in ovarian cancer: a meta-analysis. J Int Med Res. 2020;48(11):1–11.
  • Yu L, Wan F, Dutta S, et al. Autophagic programmed cell death by selective catalase degradation. Proc Natl Acad Sci USA. 2016;103(13):4952–4967.
  • Mathiew R, Karp C, Beaudoin B, et al. Autophagy suppresses tumorigenesis through elimination of p62. Cell. 2009;137(6):1062–1075.
  • Lum JJ, Bauer DE, Kong M. Growth factor regulation of autophagy and cell survival in the absence of apoptosis. Cell. 2005;120(2):237–248.
  • Wang BJ, Tang YD, Yu BY, et al. Expression of autophagy-related factor p62 for lung cancer diagnosis and prognosis: a systematic review and meta-analysis. Math Biosci Eng. 2019;16(6):6805–6821.
  • Bednarczyk M, Walkiewicz K, Koziel P, et al. Profil ekspresji bialka DRAM1 uczestniczacego w autofagii w raku jelita grubego. Badania i rozwój mlodych naukowców w Polce. Nauki medyczne i nauki o zdrowiu. Czesc II. Wydawnictwo Mlodzi Naukowcy 2016;2:14–20.
  • Bednarczyk M, Walkiewicz K, Koziel P, et al. Podstawy molekularne autofagii. Wybrane zagadnienia z biologii molekularnej oraz inzynierii materialowej. Wydawnictwo Naukowe Tygiel 2016: 92–109
  • Vicencio JM, Ortiz C, Criollo A, et al. The inositol 1,4,5-trisphosphate receptor regulates autophagy through its interaction with Beclin 1. Cell Death Differ. 2009;16(7):1006–1017.
  • Xu T, Song Q, Zhou L. Ferulic acid alleviates lipotoxicity-induced hepatocellular death through the SIRT1-regulated autophagy pathway and independently of AMPK and Akt in AML-12 hepatocytes. Nut & Met. 2021;18(13):1–13.
  • Mortensen M, Soilleux EJ, Djordjevic G, et al. The autophagy protein Atg7 is essential for hematopoietic stem cell maintenance. J Exp Med. 2011;208(3):455–467.
  • Xu X, Araki K, Li S, et al. Autophagy Is essential for effector CD8(+) T cell survival and memory formation. Nat Immunol. 2014;15(12):1152–1161.
  • Le Texier L, Lineburg KE, Cao B, et al. Autophagy-dependent regulatory T cells are critical for the control of graft-versus-host disease. JCI Insight. 2016;1(15):e86850.
  • Mouttie L L-E, Vu T, Lineburg KE, et al. Autophagy is required for stem cell mobilization by G-CSF. Blood. 2015;125(19):2933–2936.
  • Auberger P, Puissant A. Autophagy, a key mechanism of oncogenesis and resistance in leukemia. Blood. 2017;129(5):547–552.
  • Chen SJ, Bao L, Keefer K, et al. Transient receptor potential ion channel TRPM2 promotes AML proliferation and survival through modulation of mitochondrial function, ROS, and autophagy. Cell Death Dis. 2020;11(247):1–17.
  • Folkerts H, Wierenga AT, van den Heuvel FA, et al. Elevated VMP1 expression in acute myeloid leukemia amplifies autophagy and is protective against venetoclax-induced apoptosis. Cell Death Dis. 2019;10(6):421–438.
  • Nazio F, Bordi M, Cianfanelli V, et al. Autophagy and cancer stem cells: molecular mechanisms and therapeutic applications. Cell Death Dif. 2019;26(4):690–702.
  • Pei S, Minhajuddin M, Adane B, et al. AMPK/FIS1-mediated mitophagy is required for self-renewal of human AML stem cells. Cell Stem Cell. 2018;23(1):86–100.
  • Simek T, Kocabas F, Zheng J, et al. The distinct metabolic profile of hematopoietic stem cells reflects their location in a hypoxic niche. Cell Stem Cell. 2010;7(3):380–390.
  • Watson AS, Riffelmacher T, Stranks A, et al. Autophagy limits proliferation and glycolytic metabolism in acute myeloid leukemia. Cell Death Disc. 2015;1:1–9.
  • Csizmar CM, Kim DH, Sachs Z. The role of the proteasome in AML. Blood Cancer J. 2016;6(12):e503.
  • Larrue C, Saland E, Boutzen H, et al. Proteasome inhibitors induce FLT3-ITD degradation through autophagy in AML cells. Blood. 2016;127(7):882–892.
  • Fang J, Rhyasen G, Bolanos L, et al. Cytotoxic effects of bortezomib in myelodysplastic syndrome/acute myeloid leukemia depend on autophagy-mediated lysosomal degradation of TRAF6 and repression of PSMA1. Blood. 2012;120(4):858–867.
  • Cao Y, Cai J, Zhang S, et al. Autophagy sustains hematopoiesis through targeting notch. Stem Cells Dev. 2015;24(22): 2660–2673. .
  • Rudat S, Pfaus A, Cheng YY, et al. RET-mediated autophagy suppression as targetable co-dependence in acute myeloid leukemia. Leukemia. 2018;32(10): 2189–2202. .
  • Heydt Q, Larrue C, Saland E, et al. Oncogenic FLT3-ITD supports autophagy via ATF4 in acute myeloid leukemia. Oncogene. 2018;7(6): 787–797. .
  • Li P, Ji M, Lu F, et al. Degradation of AF1Q by chaperone-mediated autophagy. Exp Cell Res. 2014;327(1):48–56.
  • Dubois A, Furstoss N, Calleja A, et al. RETRACTED ARTICLE: LAMP2 expression dictates azacytidine response and prognosis in MDS/AML. Leukemia. 2019;6(6):1501–1513.
  • Allende-Vega N, Villalba M. Metabolic stress controls mutant p53 R248Q stability in acute myeloid leukemia cells. Sci Rep. 2019;9(1):5637.
  • Whitesell L, Lindquist SL. HSP90 and the chaperoning of cancer. Nat Rev Cancer. 2005;5(10):761–772.
  • Amaravadi RK, Kimmelman AC, Debnath J. Targeting autophagy in cancer: recent advances and future directions. Cancer Discov. 2019;9(9):1167–1181.
  • Palikaras K, Lionaki E, Tavernarakis N. Mechanisms of mitophagy in cellular homeostasis, physiology and pathology. Nat Cell Biol. 2018;20(9):1013–1022.
  • Eng C, Wang Z, Tkach D. Macroautophagy is dispensable for growth of KRAS mutant tumors and chloroquine efficacy. Pnas. 2016;113(1):182–187.
  • Raffiq S, McKenna S, Muller S, et al. Lysosomes in acute myeloid leukemia: potential therapeutic targets? Leukemia. 2021;35(10):2759–2770.
  • Horton SJ, Grier DG, McGonigle GJ, et al. Continuous MLL-ENL expression is necessary to establish a “Hox Code” and maintain immortalization of hematopoietic progenitor cells. Can Res. 2005;65(20):9245–9252.
  • Sumitomo Y, Koya J, Nakazaki K, et al. Cytoprotective autophagy maintains leukemia-initiating cells in murine myeloid leukemia. Blood. 2016;128(12):1614–1624.
  • Gomez-Puerto MC, Folkerts H, Wierenga A, et al. Autophagy Proteins ATG5 and ATG7 are essential for the maintenance of human CD34+ hematopoietic stem-progenitor cells. Stem Cells. 2016;34(6):1651–1663.
  • Nguyen TD, Shaid S, Vakhrusheva O, et al. Loss of the selective autophagy receptor p62 impairs murine myeloid leukemia progression and mitophagy. Blood. 2019;133(2):168–179.
  • Fay H, Dykstra K, Johnson M, et al. Mitophagy plays a key role in the anti-leukemic activity of autophagy inhibitors under hypoxia in acute myeloid leukemia. Blood. 2019;134(Supplement_1):1278–1278.
  • Li Y, Li Y, Yin J, et al. A mitophagy inhibitor targeting p62 attenuates the leukemia-initiation potential of acute myeloid leukemia cells. Cancer Lett. 2021;510:24–36.
  • Buhlman L, Damiano M, Bertolin G, et al. Functional interplay between parkin and Drp1 in mitochondrial fission and clearance. Biochim Biophys Acta. 2014;1843(9):2012–2026.
  • Chang CR, Blackstone C. Dynamic regulation of mitochondrial fission through modification of the dynamin-related protein Drp1. Ann N Y Acad Sci. 2010;1201(1):34–39.
  • Dany M, Gencer S, Nganga R, et al. Targeting FLT3-ITD signaling mediates ceramide-dependent mitophagy and attenuates drug resistance in AML. Blood. 2016;128(15):1944–1958.
  • Wang Z, Cao L, Kang R, et al. Autophagy regulates myeloid cell differentiation by p62/SQSTM1-mediated degradation of PML-RARa oncoprotein. Autophagy. 2011;7(4):401–411.
  • Schläfli AM, Isakson P, Garattini E, et al. The autophagy scaffold protein ALFY is critical for the granulocytic differentiation of AML cells. Nature. 2017;7(1):12980.
  • Zhang J, Tripathi DN, Jing J, et al. ATM functions at the peroxisome to induce pexophagy in response to ROS. Nat Cell Biol. 2015;17(10):1259–1269.
  • Hinz M, Stilmann M, Arslan SÇ, et al. A cytoplasmic ATM-TRAF6-cIAP1 module links nuclear DNA damage signaling to ubiquitin-mediated NF-?B activation. Mol Cell. 2020;40(1):63–74.
  • Qiu SW, Paterson AJ, Abraham A, et al. Role of enhanced autophagy in resistance of FLT3-ITD AML stem cells to FLT3 TKI treatment. Blood. 2018;132(Supplement 1):1358–1358.
  • Wang L, Yang L, Yang Z, et al. Glycolytic enzyme PKM2 mediates autophagic activation to promote cell survival in NPM1-mutated leukemia. Int J Biol Sci. 2019;15(4):882–894.
  • Zou Q, Tan S, Yang Z, et al. NPM1 Mutant Mediated PML Delocalization and Stabilization Enhances Autophagy and Cell Survival in Leukemic Cells. Theranostic. 2017;7(8):2289–2304.
  • Liu X, Gong Y. Isocitrate dehydrogenase inhibitors in acute myeloid leukemia. Biomark Res. 2019;27(22):1–8.
  • Falini B, Mecucci C, Tiacci E, et al. Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype. N Engl J Med. 2005;352(3):254–266.
  • Piya S, Andreeff M, Borthakur G. Targeting autophagy to overcome chemoresistance in acute myleogenous leukemia. Autophagy. 2017;13(1):214–215.
  • Ouchida AT, Li YB, Geng JF, et al. Synergistic effect of a novel autophagy inhibitor and Quizartinib enhances cancer cell death. Cell Death Dis. 2018;9(2):138.
  • Zhang W, Yu G, Zhang H, et al. Concomitant targeting of FLT3 and BTK overcomes FLT3 inhibitor resistance in acute myeloid leukemia through inhibition of autophagy. Haematologica. 2022;1–57.
  • Qiu S, Humar K, Yan C, et al. Autophagy inhibition impairs leukemia stem cell function in FLT3-ITD AML but has antagonistic interactions with tyrosine kinase inhibition. Leukemia. 2022;36(11):2621–2633.
  • Mohamadimaram M, Farsani M, Mirzaeian A, et al. Evaluation of ATG7 and light chain 3 (LC3) autophagy genes expression in AML patients. Iranian J Pharm Res. 2019;18(2): 1060–1066
  • Qiu L, Zhou G, Cao S. Targeted inhibition of ULK1 enhances daunorubicin sensitivity in acute myeloid leukemia. Life Sci. 2020;243:117234.
  • Jiang L, Zhao Y, Yang M. Inhibition of autophagy enhances apoptosis induced by bortezomib in AML cells. Oncol Lett. 2021;21(2):109–116.
  • Putyrski M, Vakhrusheva O, Bonn F, et al. Disrupting the LC3 interaction region (LIR) binding of selective autophagy receptors sensitizes AML cell lines to cytarabine. Front in Cell Dev Biol. 2020; 8: 208.
  • Dykstra K, Fa H, Massey A, et al. Inhibiting autophagy targets human leukemic stem cells and hypoxic AML blasts by disrupting mitochondrial homeostasis. Blood Adv. 2021;5(8):2087–2100.
  • Dykstra KM, Hanekamp DW, Johnson M, et al. Inhibition of the late stages of autophagy overcomes hypoxia-induced chemoresistance and targets leukemic stem cells in acute myeloid leukemia. Cancer Res. 2018;78(13):2864.
  • Xu D, Chen Y, Yang Y, et al. Autophagy activation mediates resistance to FLT3 inhibitors in acute myeloid leukemia with FLT3-ITD mutation. J Transl Med. 2022;20(1):300.
  • Koschade SE, Klann K, Shain S, et al. Translatome proteomics identifies autophagy as a resistance mechanism to on-target FLT3 inhibitors in acute myeloid leukemia. Leukemia. 2022;36(10):2396–2407.
  • Levy JMM, Towers CG, Thorburn A. Targeting autophagy in cancer. Nat Rev Cancer. 2017;17(9):528–542.
  • Machado-Neto JA, Coehlo-Silva JL, Santos F, et al. Autophagy inhibition potentiates ruxolitinib-induced apoptosis in JAK2V617F cells. Invest New Drugs. 2020;38(3):733–745.
  • Maishman T, Cutress R, Hernandez A, et al. Local recurrence and breast oncological surgery in Young women with breast Cancer: the POSH observational cohort study. Ann Sur. 2017;266(1):165–172.
  • Barnard RA, Regan D, Hansen R, et al. Autophagy inhibition delays early but not late-stage metastatic disease. J. Pharmacol. Exp Ther Med. 2016;358(2):282–293.
  • Xu X, Wang J, Tong T. A self-assembled leucine polymer sensitizes leukemic stem cells to chemotherapy by inhibiting autophagy in acute myeloid leukemia. Haematologica. 2022;107(10):2344–2355.
  • Guo JY, Xia B, White E. Autophagy-mediated tumor promotion. Cell. 2016;155(6):1216–1219.
  • White E. Deconvoluting the context-dependent role for autophagy in cancer. Nature Rev Cancer. 2021;12(6):401–410.
  • Anding AL, Baehrecke EH. Cleaning house: selective autophagy of organelles. Dev Cell. 2017;41(1):10–22.
  • Wu WK, Coffelt S, Cho C, et al. The autophagic paradox in cancer therapy. Oncogene. 2012;31(8):939–953.
  • Seo W, Silwal P, Song I. The dual role of autophagy in acute myeloid leukemia. J Hematol Oncol. 2022;15(1):51.
  • Zois CE, Koukourakis MI. Radiation-induced autophagy in normal and cancer cells: towards novel cytoprotection and radio-sensitization policies? Autophagy. 2009;5(4):442–450.
  • Garbar C, Mascaux C, Giustiniani J, et al. Chemotherapy treatment induces an increase of autophagy in the luminal breast cancer cell MCF7, but not in the triple-negative MDA- MB231. Sci Rep. 2017;7(1):7201.
  • Sui X, Chen R, Wang Z, et al. Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment. Cell Death Dis. 2013;4(10):e838.
  • Chen X, Clark J, Wunderlich M. Autophagy is dispensable for Kmt2a/Mll-Mllt3/Af9 AML maintenance and anti-leukemic effect of chloroquine. Autophagy. 2017;13(5):955–966.
  • Mandelbaum J, Rollins N, Shah P, et al. Identification of a lung cancer cell line deficient in atg7-dependent autophagy. Autophagy. 2015;11(1):1–26.
  • Huang M, Garcia J, Thomas D, et al. Autophagy mediates proteolysis of NPM1 and HEXIM1 and sensitivity to BET inhibition in AML cells. Oncotarget. 2016;7(46):74917–74930.
  • Amaravadi R, Kimmelman AC, White E. Recent insights into the function of autophagy in cancer. Genes Dev. 2016;30(17):1913–1930.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.